Chemoinformaics analysis of 5-Phenyl-2-oxazolidinone
Molecular Weight | 163.176 | nRot | 1 |
Heavy Atom Molecular Weight | 154.104 | nRig | 12 |
Exact Molecular Weight | 163.063 | nRing | 2 |
Solubility: LogS | -1.983 | nHRing | 1 |
Solubility: LogP | 1.43 | No. of Aliphatic Rings | 1 |
Acid Count | 0 | No. of Aromatic Rings | 1 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 21 | No. of Aliphatic Hetero Cycles | 1 |
No. of Heavy Atom | 12 | No. of Aromatic Carbocycles | 1 |
nHetero | 3 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 9 | No. of Saturated Hetero Cycles | 1 |
No. of Carbon atom | 9 | No. of Saturated Rings | 1 |
No. of Nitrogen atom | 1 | No. of Arom Atom | 6 |
No. of Oxygen atom | 2 | No. of Arom Bond | 6 |
nHA | 2 | APOL | 23.7351 |
nHD | 1 | BPOL | 12.2029 |
QED | 0.68 |
Synth | 2.64 |
Natural Product Likeliness | 1.01 |
NR-PPAR-gamma | 0.006 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Rejected |
Pgp-inh | 0.001 |
Pgp-sub | 0.017 |
HIA | 0.06 |
CACO-2 | -4.409 |
MDCK | 0.0000769 |
BBB | 0.963 |
PPB | 0.710019 |
VDSS | 1.137 |
FU | 0.234931 |
CYP1A2-inh | 0.743 |
CYP1A2-sub | 0.158 |
CYP2c19-inh | 0.486 |
CYP2c19-sub | 0.776 |
CYP2c9-inh | 0.132 |
CYP2c9-sub | 0.786 |
CYP2d6-inh | 0.023 |
CYP2d6-sub | 0.841 |
CYP3a4-inh | 0.038 |
CYP3a4-sub | 0.305 |
CL | 6.033 |
T12 | 0.746 |
hERG | 0.044 |
Ames | 0.786 |
ROA | 0.176 |
SkinSen | 0.425 |
Carcinogencity | 0.305 |
EI | 0.084 |
Respiratory | 0.065 |
NR-Aromatase | 0.004 |
Antiviral | No |
Prediction | 0.871 |